MapLight Therapeutics, Inc. (MPLT)
12.97
+0.37
(+2.94%)
USD |
NASDAQ |
Aug 31, 16:00
13.02
+0.05
(+0.39%)
After-Hours: 20:00
MapLight Therapeutics Cash and Short Term Investments (Quarterly) : 304.72M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 304.72M |
| March 31, 2026 | 310.11M |
| December 31, 2025 | 305.10M |
| September 30, 2025 | 227.17M |
| Date | Value |
|---|---|
| June 30, 2025 | 60.47M |
| March 31, 2025 | 92.26M |
| June 30, 2024 | |
| March 31, 2024 | 179.81M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Evommune, Inc. | 200.79M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Cullinan Therapeutics, Inc. | 334.54M |
| Mineralys Therapeutics, Inc. | 661.41M |
| Apogee Therapeutics, Inc. | 971.93M |